NYSE · Medical - Healthcare Plans

HUM (HUM) Stock

$394.58 +2.96% NYSE: HUM Healthcare

Valuation

MetricValue
Price$394.58
Market Cap$47.38B
P/E Ratio36.72
P/B Ratio2.45
P/S Ratio0.32
EPS (TTM)$9.84
52-Week High$428.88
52-Week Low$163.11
Dividend Yield0.91%

Financials & Margins

MetricValue
ROE6.91%
ROA2.23%
ROCE5.91%
Gross Margin1.12%
Operating Margin1.12%
Net Margin0.88%
Debt/Equity0.74
Current Ratio0.72

Annual Financials (USD)

Metric20212022202320242025
Revenue$83.6B$92.9B$106.4B$117.8B$129.7B
Operating Profit$3.4B$3.6B$3.3B$1.6B$1.5B
Net Profit$2.9B$2.8B$2.5B$1.2B$1.2B
EPS$22.67$22.08$20.00$9.98$9.84
Op Margin4.1%3.8%3.1%1.4%1.1%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$44.7B$43.7B$46.9B$46.3B$48.8B
Total Liabilities$28.6B$28.4B$30.6B$29.9B$31.0B
Cash$3.4B$5.1B$4.7B$2.2B$4.2B
Borrowings$13.2B$11.8B$12.3B$12.3B$12.9B

Latest News

Sector Update: Healthcare Stocks Advance Late Afternoon MT Newswires · Jul 13, 2026 Humana Shares Rise After Upgrade From Wells Fargo MT Newswires · Jul 13, 2026 Is UNH Stock Worth Buying Ahead of Q2 Earnings? Key Estimates to Watch Zacks · Jul 13, 2026 The Premium On CVS Stock Vs What Its Peers Deliver Trefis · Jul 13, 2026 Humana Eyes 3% Medicare Advantage Margin: Can It Deliver? Zacks · Jul 13, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$2.3B$4.6B$4.0B$3.0B$921.0M
Investing Cash Flow$-7.9B$-2.1B$-4.5B$-3.5B$1.7B
Financing Cash Flow$-389.0M$-128.0M$-848.0M$-2.3B$-1.2B
Net Cash Flow$-1.3B$1.7B$-367.0M$-2.5B$2.0B
Free Cash Flow$920.0M$3.5B$3.0B$2.4B$375.0M

Valuation & Return Ratios

MetricValue
PEG Ratio-1.98
EV / EBITDA17.70
FCF Yield-0.94%
Quick Ratio1.74
Interest Coverage2.87
Return 1Y31.29%
Return 3Y-16.93%
Return 5Y1.32%

Ownership

Insiders Held0.21%
Institutions Held99.89%
Institutions Float Held100.10%
Institutional HolderSharesReport Date
Dodge & Cox Inc.11,380,6732026-03-31
Blackrock Inc.10,199,0552026-03-31
Vanguard Capital Management LLC7,838,7622026-03-31
Vanguard Portfolio Management LLC5,808,4352026-03-31
Pzena Investment Management LLC5,470,9822026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
A $149.93 -2.36% 30.48 $42.35B 0.66%
ALC $71.75 -0.43% 55.39 $34.99B 0.50%
CNC $65.20 +1.34% -5.11 $32.21B 0.00%
GEHC $70.42 -1.14% 20.45 $31.81B 0.20%
HLNHaleon plc $9.76 +0.51% 19.49 $42.98B 2.77%

About HUM

HUM is led by CEO James A. Rechtin, employs 65,680 people, headquartered in Louisville, US, publicly traded since 1981.

HUM stock trades at $394.58 with a market capitalization of $47.38B. The stock is valued at a price-to-earnings (P/E) ratio of 36.72, price-to-book of 2.45, price-to-sales of 0.32. Over the past 52 weeks the stock has ranged between $163.11 and $428.88, and currently trades 8.0% below its 52-week high. It pays a dividend yielding 0.91%.

On profitability, HUM generates a return on equity (ROE) of 6.91%, return on capital employed of 5.91%, an operating margin of 1.12%, a net profit margin of 0.88%.

In its most recent fiscal year, HUM reported annual revenue of $129.7B, net profit of $1.2B, revenue has compounded at 10.9% a year over the last five years, profit at -18.8% a year.

The balance sheet shows a debt-to-equity ratio of 0.74, a current ratio of 0.72, total assets of $48.8B, $4.2B in cash and equivalents.

HUM has a beta of 0.74 (less volatile than the overall market).

Related Healthcare Stocks

LLY Drug Manufacturers - General $1159.93 +0.28% JNJ Drug Manufacturers - General $271.19 +2.01% ABBV Drug Manufacturers - General $259.99 +1.39% MRK Drug Manufacturers - General $149.94 +1.48% UNH Medical - Healthcare Plans $396.30 +1.77% NVS Drug Manufacturers - General $161.25 +6.04% AZN Drug Manufacturers - General $162.47 +0.21% AMGN Drug Manufacturers - General $438.12 +1.92% TMO Medical - Diagnostics & Research $600.50 -2.69% NVO Biotechnology $45.12 -0.46% ABT Medical - Devices $108.97 -1.26% GILD Drug Manufacturers - General $149.92 +2.45%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNYSE High ROE StocksAll stock screens
Run Stock Screener Investing Guides